How much is House Rx worth in 2026?

House Rx has a current valuation of N/A based on their Early Stage VC round and secondary market data.

How much funding has House Rx raised?

House Rx has raised $84.9M in total funding across 1 funding rounds.

House Rx

Other Healthcare Technology SystemsWebsite

House Rx valuation and funding history | Last updated: November 12, 2025 | 1 funding rounds

Current Valuation

N/A

As of November 12, 2025

Total Funding Raised

$84.9M

Across 1 round

Last Round

Early Stage VC

$55.0M

Last Funding

Nov 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
November 12, 2025	Early Stage VC (Series B)	$55.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

House Rx is currently valued at N/A as of November 12, 2025. The company has raised a total of $84.9M in funding across 1 funding round.

Track House Rx Valuation Updates

Get notified when House Rx raises new funding or valuation changes

Explore More Data

Detailed analysis for House Rx

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock House Rx's valuation history, funding rounds, and growth metrics.

No credit card required

What is House Rx Worth in 2026?

House Rx is a leading private company in the Other Healthcare Technology Systems sector. Track House Rx's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How House Rx Valuation is Determined

Private company valuations like House Rx's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.